Stocks and securities in focus
| Security | Change (%) | 1w | 1m ▲ | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Revance Therapeutics Inc. | -2.560% | - | - | - | - | - | - |
| Carisma Therapeutics Inc. | 1.100% | -4.688% | -39.039% | -81.277% | -65.493% | -98.567% | -95.499% |
| ImmunityBio Inc. | -4.090% | -17.009% | -25.573% | 142.034% | -9.237% | -54.513% | 277.445% |
| Esperion Therapeutis.Inc. | -5.600% | -15.652% | -13.680% | 15.411% | -34.373% | -85.075% | -94.593% |
| Sage Therapeutics Inc. | -0.460% | -7.964% | -12.682% | -73.792% | -55.970% | -75.887% | -93.987% |
| Eli Lilly Corp. | -4.160% | -0.607% | -12.678% | 77.419% | 39.583% | 254.497% | 628.117% |
| MacroGenics Inc. | -6.060% | -31.294% | -12.180% | -21.435% | -61.067% | -83.557% | -73.531% |
| Sarepta Therapeutics | 0.530% | -1.874% | -6.969% | 38.831% | 50.882% | 130.969% | 1.505% |
| Coherus Bioscien. | -6.020% | -21.368% | -4.351% | -68.676% | -59.145% | -88.811% | -91.917% |
| Savara Inc. | 0.470% | 1.923% | 3.922% | 31.677% | -1.852% | 296.262% | 86.620% |
| Alnylam Pharmace. | -0.600% | 15.164% | 8.023% | 45.673% | 40.734% | 66.233% | 255.248% |
| Insmed Inc. | 1.480% | 0.735% | 11.382% | 244.221% | 139.510% | 242.500% | 340.741% |
| Ardelyx Inc. | 7.540% | 7.309% | 12.851% | 50.407% | -3.979% | 293.617% | 152.790% |
| Ocular Therapeutix Inc. | -3.370% | -8.170% | 14.529% | 81.508% | 69.828% | -24.989% | 61.496% |
| Puma Biotechnology Inc. | 10.940% | -0.795% | 21.305% | 7.901% | -10.474% | -47.206% | -56.797% |
| Fate Therapeutics Inc. | -8.630% | -15.342% | 39.362% | 23.485% | 19.179% | -94.088% | -76.778% |
| G1 Therapeutics | -6.170% | 0.385% | 72.264% | 87.282% | 32.800% | -74.943% | - |